Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Mirum Pharmaceuticals (MIRM) Income from Continuing Operations (2020 - 2025)

Mirum Pharmaceuticals has reported Income from Continuing Operations over the past 6 years, most recently at 5730000.0 for Q4 2025.

  • Quarterly results put Income from Continuing Operations at 5730000.0 for Q4 2025, up 75.91% from a year ago — trailing twelve months through Dec 2025 was 23363000.0 (up 73.43% YoY), and the annual figure for FY2025 was 23363000.0, up 73.43%.
  • Income from Continuing Operations for Q4 2025 was 5730000.0 at Mirum Pharmaceuticals, down from 2905000.0 in the prior quarter.
  • Over the last five years, Income from Continuing Operations for MIRM hit a ceiling of 57280000.0 in Q4 2021 and a floor of 74038000.0 in Q2 2023.
  • Median Income from Continuing Operations over the past 5 years was 26100500.0 (2022), compared with a mean of 24731950.0.
  • Biggest five-year swings in Income from Continuing Operations: soared 253.97% in 2021 and later tumbled 175.01% in 2023.
  • Mirum Pharmaceuticals' Income from Continuing Operations stood at 57280000.0 in 2021, then crashed by 163.6% to 36431000.0 in 2022, then rose by 2.12% to 35659000.0 in 2023, then soared by 33.28% to 23790000.0 in 2024, then skyrocketed by 75.91% to 5730000.0 in 2025.
  • The last three reported values for Income from Continuing Operations were 5730000.0 (Q4 2025), 2905000.0 (Q3 2025), and 5861000.0 (Q2 2025) per Business Quant data.